NFKB1 and gastric cancer: For instance, Kang DW and colleagues showed that rebamipide, a mucosal-protective antiulcer agent, contributes to anti-tumorigenic effect of gastric cancer cells via the inhibition of the H. pylori cagA-NF-κB-PLD1 signaling pathway [22].